Table 1.

Baseline characteristics of participants

Baseline characteristicTotal cohort
(N = 839)
Active vitamin D
(n = 203)
Active omega-3 (n = 224)Active vitamin D + omega-3
(n = 198)
Both placebo
(n = 214)
P value
Age, mean (SD), y 64.8 (6.4) 64.5 (6.0) 65.0 (6.5) 64.5 (6.5) 65.1 (6.6) .67 
Median (IQR) 64.3 (60.3-69.0) 64.2 (60.3-68.2) 64.3 (60.1-68.9) 63.8 (60.3-69.2) 64.5 (60.4-69.2) .83 
Sex       
Male 450 (53.6) 111 (54.7) 116 (51.8) 105 (53.0) 118 (55.1) .89 
Female 389 (46.4) 92 (45.3) 108 (48.2) 93 (47.0) 96 (44.9)  
Race/ethnicity,        
Non-Hispanic White 709 (86.1) 169 (84.1) 181 (83.0) 171 (88.1) 188 (89.5) .16 
Non-White  114 (13.9) 32 (15.9) 37 (17.0) 23 (11.9) 22 (10.5)  
BMI§  26.3 (24.0-29.6) 26.4 (23.7-29.0) 26.6 (24.4-30.3) 26.0 (24.1-29.2) 25.7 (23.6-29.7) .17 
Hemoglobin,§ g/dL 13.7 (13.1-14.5) 13.8 (13.2-14.4) 13.7 (13.1-14.4) 13.7 (13.0-14.5) 13.8 (13.0-14.6) .91 
MCV,§, fL 91.0 (88.0-93.0) 91.0 (88.0-93.0) 91.0 (88.5-93.0) 91.0 (88.0-93.0) 90.5 (88.0-93.0) .60 
25(OH)-vitamin D,§ ng/mL 28.0 (22.0-34.0) 27.0 (22.0-34.0) 29.0 (20.5-34.0) 28.0 (22.0-33.0) 29.0 (24.0-33.0) .23 
Cr,§ mg/dL 0.82 (0.71-0.94) 0.80 (0.70-0.93) 0.83 (0.72-0.95) 0.84 (0.72-0.93) 0.82 (0.71-0.97) .53 
IL-6,§, pg/mL 2.3 (1.7-3.4) 2.5 (1.8-3.8) 2.4 (1.8-3.4) 2.1 (1.7-3.3) 2.1 (1.7-3.1) .06 
CRP,,# mg/L 1.2 (0.6-2.6) 1.0 (0.5-2.5) 1.4 (0.6-2.8) 1.3 (0.6-2.5) 1.1 (0.6-2.4) .36 
Total fish intake, servings per wk 1.87 (0.93-2.93) 1.87 (0.93-2.93) 1.87 (1.00-2.47) 1.93 (1.40-3.00) 1.93 (1.00-2.93) .34 
Baseline characteristicTotal cohort
(N = 839)
Active vitamin D
(n = 203)
Active omega-3 (n = 224)Active vitamin D + omega-3
(n = 198)
Both placebo
(n = 214)
P value
Age, mean (SD), y 64.8 (6.4) 64.5 (6.0) 65.0 (6.5) 64.5 (6.5) 65.1 (6.6) .67 
Median (IQR) 64.3 (60.3-69.0) 64.2 (60.3-68.2) 64.3 (60.1-68.9) 63.8 (60.3-69.2) 64.5 (60.4-69.2) .83 
Sex       
Male 450 (53.6) 111 (54.7) 116 (51.8) 105 (53.0) 118 (55.1) .89 
Female 389 (46.4) 92 (45.3) 108 (48.2) 93 (47.0) 96 (44.9)  
Race/ethnicity,        
Non-Hispanic White 709 (86.1) 169 (84.1) 181 (83.0) 171 (88.1) 188 (89.5) .16 
Non-White  114 (13.9) 32 (15.9) 37 (17.0) 23 (11.9) 22 (10.5)  
BMI§  26.3 (24.0-29.6) 26.4 (23.7-29.0) 26.6 (24.4-30.3) 26.0 (24.1-29.2) 25.7 (23.6-29.7) .17 
Hemoglobin,§ g/dL 13.7 (13.1-14.5) 13.8 (13.2-14.4) 13.7 (13.1-14.4) 13.7 (13.0-14.5) 13.8 (13.0-14.6) .91 
MCV,§, fL 91.0 (88.0-93.0) 91.0 (88.0-93.0) 91.0 (88.5-93.0) 91.0 (88.0-93.0) 90.5 (88.0-93.0) .60 
25(OH)-vitamin D,§ ng/mL 28.0 (22.0-34.0) 27.0 (22.0-34.0) 29.0 (20.5-34.0) 28.0 (22.0-33.0) 29.0 (24.0-33.0) .23 
Cr,§ mg/dL 0.82 (0.71-0.94) 0.80 (0.70-0.93) 0.83 (0.72-0.95) 0.84 (0.72-0.93) 0.82 (0.71-0.97) .53 
IL-6,§, pg/mL 2.3 (1.7-3.4) 2.5 (1.8-3.8) 2.4 (1.8-3.4) 2.1 (1.7-3.3) 2.1 (1.7-3.1) .06 
CRP,,# mg/L 1.2 (0.6-2.6) 1.0 (0.5-2.5) 1.4 (0.6-2.8) 1.3 (0.6-2.5) 1.1 (0.6-2.4) .36 
Total fish intake, servings per wk 1.87 (0.93-2.93) 1.87 (0.93-2.93) 1.87 (1.00-2.47) 1.93 (1.40-3.00) 1.93 (1.00-2.93) .34 

Data are presented as n (%) and median (IQR) unless otherwise specified.

BMI, body mass index; Cr, creatinine; MCV, mean corpuscular volume.

P value calculated using non-Hispanic White as the reference group.

Sample size for race/ethnicity of 823 with 16 missing data points.

Non-White includes African American, Hispanic, Asian, American Indian/Alaskan Native, and other/unknown.

§

P values were calculated using nonparametric tests given nonnormal distributions.

Sample size for MCV of 838 with 1 missing data point.

Sample size for IL-6 of 563 with 276 missing data points.

#

Sample size for CRP of 833 with 6 missing data points.

or Create an Account

Close Modal
Close Modal